

Virginia Integrated Primary Care and Weight Loss Center operates in Richmond, VA, delivering physician-supervised obesity management alongside comprehensive primary care services. The practice integrates evidence-based weight loss interventions with chronic disease management, women's health services, and nutrition counseling under one clinical roof. Board-certified family medicine physicians with specialized training in obesity medicine lead the clinical team, holding active memberships in the Obesity Society and the Obesity Medicine Association, ensuring treatment protocols align with current metabolic research and clinical guidelines.
The clinic's obesity management program centers on FDA-approved GLP-1 receptor agonist therapy, specifically liraglutide and semaglutide, prescribed following comprehensive metabolic assessment and patient-specific evaluation. Liraglutide treatment typically begins at 0.6 mg daily with gradual titration to therapeutic doses of 3.0 mg, while semaglutide protocols follow weekly subcutaneous administration starting at 0.25 mg and advancing to maintenance doses based on individual response and tolerability. These peptide therapies function by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to reduce appetite and caloric intake. Providers monitor patients through regular follow-up appointments that track weight trends, assess medication tolerance, adjust dosing protocols, and address any gastrointestinal side effects or contraindications that may emerge during treatment.
Physicians at Virginia Integrated Primary Care maintain credentials through the American Academy of Family Physicians and pursue ongoing education in metabolic disorders and obesity pharmacotherapy. The clinical approach combines peptide therapy with structured nutrition counseling delivered by registered dietitians who create individualized meal plans addressing macronutrient balance, portion control, and sustainable dietary modifications. Patients receive education on reading nutrition labels, managing emotional eating patterns, and implementing behavioral strategies that support long-term weight maintenance beyond the active medication phase. This multidisciplinary model addresses obesity as a chronic disease requiring medical intervention rather than a willpower issue, reducing stigma while improving clinical outcomes.
New patients undergo initial consultations that include body composition analysis, metabolic panel testing, thyroid function assessment, and review of weight history to identify underlying factors contributing to obesity. Providers screen for contraindications to GLP-1 therapy including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. The practice manages co-existing conditions frequently associated with obesity, including type 2 diabetes, hypertension, dyslipidemia, polycystic ovary syndrome, and sleep apnea, allowing for coordinated care that addresses metabolic health comprehensively. Women's health services include hormone evaluation, menopause management, and reproductive health counseling integrated with weight management protocols.
Virginia Integrated Primary Care serves Richmond and surrounding central Virginia communities through in-person appointments at their Richmond location. The practice accepts most major insurance plans and provides prior authorization support for GLP-1 medications, though patients should verify coverage specifics with their insurance carrier as formulary restrictions and step therapy requirements vary by plan. Appointment scheduling accommodates working patients with extended hours, and the primary care integration allows patients to address multiple health concerns during single visits rather than coordinating care across multiple specialists. This accessibility model reduces barriers to sustained obesity treatment while maintaining continuity of care essential for chronic disease management success.

MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


